Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AMGN

AMGEN Inc.

Jul 26 • 04:00PM ET

334.85

Dollar change +0.55
Percentage change 0.16	%

Healthcare • Drug Manufacturers - General • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ SCHD SPY IVV DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	47.88	EPS (ttm)	6.99	Insider Own	0.23%	Shs Outstand	535.40M	Perf Week	1.07%
Market Cap	179.62B	Forward P/E	16.16	EPS next Y	20.72	Insider Trans	-0.17%	Shs Float	535.19M	Perf Month	7.04%
Income	3.76B	PEG	8.03	EPS next Q	5.00	Inst Own	77.95%	Short Float	1.79%	Perf Quarter	24.30%
Sales	29.35B	P/S	6.12	EPS this Y	4.59%	Inst Trans	-1.47%	Short Ratio	3.89	Perf Half Y	7.93%
Book/sh	9.36	P/B	35.77	EPS next Y	6.22%	ROA	4.14%	Short Interest	9.58M	Perf Year	42.36%
Cash/sh	18.10	P/C	18.50	EPS next 5Y	5.97%	ROE	72.57%	52W Range	228.21 - 346.85	Perf YTD	16.26%
Dividend Est.	9.24 (2.76%)	P/FCF	25.31	EPS past 5Y	-0.22%	ROI	5.78%	52W High	-3.46%	Beta	0.57
Dividend TTM	8.76 (2.62%)	Quick Ratio	0.98	Sales past 5Y	3.42%	Gross Margin	66.17%	52W Low	46.73%	ATR (14)	7.08
Dividend Ex-Date	May 16, 2024	Current Ratio	1.42	EPS Y/Y TTM	-52.50%	Oper. Margin	24.84%	RSI (14)	66.98	Volatility	2.21% 2.16%
Employees	26700	Debt/Eq	12.75	Sales Y/Y TTM	13.18%	Profit Margin	12.82%	Recom	2.17	Target Price	318.89
Option/Short	Yes / Yes	LT Debt/Eq	11.96	EPS Q/Q	-103.99%	Payout	68.24%	Rel Volume	0.61	Prev Close	334.30
Sales Surprise	-0.06%	EPS Surprise	2.09%	Sales Q/Q	22.19%	Earnings	Aug 06 AMC	Avg Volume	2.47M	Price	334.85
SMA20	3.45%	SMA50	6.64%	SMA200	15.38%	Trades		Volume	1,514,615	Change	0.16%

Date	Action	Analyst	Rating Change	Price Target Change
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320
Apr-24-23	Reiterated	Oppenheimer	Outperform	$292 → $290
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $265
Feb-13-23	Reiterated	Truist	Buy	$280 → $260
Nov-18-22	Initiated	Credit Suisse	Underperform	$240
Oct-31-22	Downgrade	Barclays	Equal Weight → Underweight	$234
Oct-11-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$257 → $279
May-23-22	Initiated	SVB Leerink	Mkt Perform	$256

Show Previous Ratings

Today 05:50PM	Amgen (AMGN) Advances But Underperforms Market: Key Facts (Zacks)
Jul-25-24 06:00PM	Amgen (AMGN) Stock Moves -0.39%: What You Should Know (Zacks)
03:18PM	Amgen Surges As Weight-Loss Trials Drive Excitement (Investor's Business Daily)
02:26AM	CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now? (Insider Monkey)
Jul-24-24 03:40PM	3 Fabulous Growth Stocks to Buy and Hold Forever (InvestorPlace)
09:00AM	Loading…
Jul-23-24 09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
03:52AM	Nanotechnology in medicine: Who are the leading public companies? (Medical Device Network)
Jul-22-24 04:12AM	Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated (Clinical Trials Arena)
Jul-19-24 05:50PM	Amgen (AMGN) Ascends While Market Falls: Some Facts to Note (Zacks)
07:00AM	Rivals Emerge to Ozempic and Zepboundbut With a Lag (The Wall Street Journal)
Jul-18-24 06:00PM	Amgen (AMGN) Dips More Than Broader Market: What You Should Know (Zacks)
Jul-16-24 06:30AM	3 Quantum AI Stocks That Could Redefine Computing (InvestorPlace)
Jul-15-24 09:04PM	3 Biotech Stocks to Buy Now: Q3 Edition (InvestorPlace)
12:10PM	Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:00AM	Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value (GuruFocus.com)
07:58AM	Loading…
07:58AM	What Is the Dividend Payout for Amgen Stock? (Motley Fool)
Jul-14-24 06:30AM	3 Dividend Growth Stocks to Buy and Hold (Motley Fool)
Jul-12-24 05:50PM	Amgen (AMGN) Rises Higher Than Market: Key Facts (Zacks)
02:29PM	Trade Tracker: Kevin Simpson sells Cisco and buys more TJX Companies and Amgen (CNBC TV)
10:53AM	Amgens Imdelltra BiTEs into SCLC treatment drought (Clinical Trials Arena)
09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jul-09-24 11:17AM	What The Quest For New Cholesterol Treatments Means For Novartis, Merck And Patients (Investor's Business Daily)
09:51AM	Amgen Inc. (AMGN): Hedge Funds Are Bullish on This Blue Chip Dividend Stock Now (Insider Monkey)
09:25AM	10 Best Blue Chip Dividend Stocks To Buy (Insider Monkey)
06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace)
Jul-08-24 06:00PM	Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know (Zacks)
10:38AM	3 Small-Cap Stocks With Explosive 2X Growth Potential (InvestorPlace)
10:04AM	3 Dividend Stocks Crushing the S&P 500 With 30%+ Annual Total Returns (InvestorPlace)
Jul-05-24 05:52AM	EAN 2024: The role of B cells in shaping rituximab use in generalised MG (Clinical Trials Arena)
Jul-04-24 06:35AM	The 3 Best Healthcare Stocks to Buy in July 2024 (InvestorPlace)
05:50AM	Loading…
05:50AM	Forget Eli Lilly: 3 Biotech Stocks to Buy Instead (Motley Fool)
Jul-03-24 09:05AM	Health Care Stocks With A Long History Of Dividend Growth And Solid Yields (Benzinga)
Jul-01-24 08:00AM	Amgen Inc: An Exploration into Its Intrinsic Value (GuruFocus.com)
01:00AM	10 clinical trials to watch in the second half of 2024 (BioPharma Dive)
Jun-29-24 03:23PM	How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth? (Benzinga)
08:45AM	1 Dividend Growth Stock to Buy and Hold for 10 Years (Motley Fool)
Jun-27-24 06:45AM	Can Amgen Stock Keep Trouncing the S&P 500? (Motley Fool)
Jun-26-24 10:48AM	Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst (Yahoo Finance Video)
03:12AM	Pharma M&A: The top high value deals in 2023 (Pharmaceutical Technology)
Jun-25-24 05:50PM	Why Amgen (AMGN) Outpaced the Stock Market Today (Zacks)
07:53AM	BMS expands Krazatis FDA label to include colorectal cancer (Clinical Trials Arena)
Jun-24-24 12:02PM	BMS expands Krazatis FDA label to include colorectal cancer (Pharmaceutical Technology)
Jun-21-24 12:14PM	The 30-stock secret: Dont fight Papa Dow (Yahoo Finance Video)
Jun-20-24 06:00PM	Amgen (AMGN) Gains As Market Dips: What You Should Know (Zacks)
08:45AM	Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 (GlobeNewswire)
08:15AM	Where Will Amgen Be in 5 Years? (Motley Fool)
Jun-18-24 09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
Jun-17-24 03:27PM	7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline (InvestorPlace)
09:54AM	Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment (Zacks)
08:00AM	Unlocking Intrinsic Value: Analysis of Amgen Inc (GuruFocus.com)
04:32AM	FDA approves Amgens BLINCYTO for acute lymphoblastic leukaemia (Pharmaceutical Technology)
Jun-14-24 06:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
04:21PM	FDA APPROVES BLINCYTO (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE (PR Newswire)
Jun-13-24 05:50PM	Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:00AM	Why It's A New Day For COPD Patients And Regeneron, Sanofi, Verona Stocks (Investor's Business Daily)
Jun-12-24 09:00AM	AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024 (PR Newswire)
03:29AM	Amgen (AMGN) Stock Fell After Some Concerns Regarding The Released Clinical Data (Insider Monkey)
Jun-11-24 09:39AM	Is Amgen Inc (NASDAQ:AMGN) the Top Dividend Stock to Buy in 2024? (Insider Monkey)
Jun-09-24 09:00AM	Top Dividend Stocks to Buy in 2024 According to Billionaire Paul Tudor Jones (Insider Monkey)
Jun-07-24 05:50PM	Why Amgen (AMGN) Dipped More Than Broader Market Today (Zacks)
09:00AM	Is Trending Stock Amgen Inc. (AMGN) a Buy Now? (Zacks)
Jun-06-24 11:59AM	Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease (Zacks)
06:26AM	Amgen reports positive data from Phase III IgG4-RD treatment trial (Clinical Trials Arena)
Jun-05-24 04:00PM	AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
03:26PM	Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal (Benzinga)
09:00AM	AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD) (PR Newswire)
Jun-03-24 04:00PM	AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
09:00AM	The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy. (Motley Fool)
08:00AM	Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value (GuruFocus.com)
May-31-24 12:20PM	The Most Profitable Biotechnology Company in the World (Insider Monkey)
12:18PM	15 Most Profitable Biotechnology Companies in the World (Insider Monkey)
May-29-24 02:51PM	Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug (Benzinga)
08:15AM	Where Will Amgen Be in 3 Years? (Motley Fool)
04:25AM	FDA approves Amgens interchangeable biosimilar Bkemv (Pharmaceutical Technology)
May-28-24 05:56PM	Nvidia, advances in cancer research, climate change under Trump: Market Domination (Yahoo Finance Video)
04:48PM	Tapping into the GLP-1 hype? Consider these pharma stocks. (Yahoo Finance Video)
11:32AM	OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF (InvestorPlace)
09:00AM	AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024 (PR Newswire)
May-27-24 09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
03:02AM	The Biggest Biotechnology Company in Europe (Insider Monkey)
May-26-24 06:53AM	Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It? (Motley Fool)
May-25-24 11:15PM	The Biggest Publicly Traded Biotech Company (Insider Monkey)
11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-24-24 12:16PM	Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More (PR Newswire)
07:00AM	Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now (InvestorPlace)
May-22-24 05:17PM	Top 20 Largest Publicly Traded Healthcare Companies (Insider Monkey)
05:41AM	Roches Tina-quant Lp(a) test receives FDA breakthrough device designation (Medical Device Network)
May-21-24 09:44AM	7 Reliable Blue-Chip Stocks That Cannot Miss (InvestorPlace)
May-20-24 04:38PM	Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population (Benzinga)
01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
08:00AM	The Art of Valuation: Discovering Amgen Inc's Intrinsic Value (GuruFocus.com)
07:48AM	HSBC Adjusts Price Target on Amgen to $356 From $322 (MT Newswires)
06:47AM	Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results (MT Newswires)
May-19-24 05:15PM	NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE TO HELP PATIENTS LIVING WITH COPD (PR Newswire)
06:15AM	Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market? (Motley Fool)
May-17-24 03:02PM	Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next? (InvestorPlace)
11:47AM	Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC (Zacks)
08:24AM	Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk (Motley Fool)
08:06AM	FDA approves Amgen drug for tough-to-treat form of lung cancer (BioPharma Dive)
04:31AM	Amgens IMDELLTRA receives FDA approval for lung cancer treatment (Pharmaceutical Technology)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	May 03 '24	Sale	313.09	2,117	662,802	9,883	May 03 07:48 PM
Grygiel Nancy A.	SVP & CCO	Dec 04 '23	Sale	273.03	2,096	572,276	10,874	Dec 04 07:41 PM
Graham Jonathan P	EVP, Gen. Counsel & Secy.	Nov 08 '23	Sale	272.81	10,000	2,728,136	28,078	Nov 13 08:30 PM
AMGEN INC	10% Owner	Sep 19 '23	Buy	17.00	1,764,705	29,999,985	35,368,653	Sep 19 07:52 PM
Gordon Murdo	EVP, Global Commercial Ops	Aug 10 '23	Sale	262.43	9,558	2,508,306	44,308	Aug 11 06:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc.

Upgrade your FINVIZ experience